ArticleBMC public health2025
Impacts of the COVID-19 pandemic on tuberculosis patients' healthcare-seeking behaviors and doctors' diagnosis delays.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and risk factors of care-seeking delay among students with pulmonary tuberculosis in Wuhan, China, 2012-2025.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionSince the onset of the Corona Virus Disease 2019 (COVID-19) pandemic, global healthcare systems have faced unprecedented challenges. To control the spread of COVID-19, China implemented multiple nonpharmaceutical interventions (NPIs). These measures have significantly altered people's healthcare-seeking behaviors. This study aims to investigate the impact of the COVID-19 pandemic on healthcare-seeking behaviors and doctor s' diagnostic delays among pulmonary tuberculosis patients, providing systematic information for future responses to pandemics of other "X diseases".
methodsWe selected Changzhou and Suzhou as research sites in eastern China. Pulmonary tuberculosis patients diagnosed from 2018 to 2022 were recruited as study subjects. Based on the occurrence of the COVID-19 pandemic and the measures implemented at the study sites from 2020 to 2022, the study period was classified into the prepandemic, initial outbreak, regular management, strict NPI implementation, regular management, and transition periods. Patient and diagnosis delays were calculated. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to estimate the risk of delay using Cox regression models.
resultsA total of 6,764 tuberculosis patients from Changzhou and 15,140 tuberculosis patients from Suzhou who were diagnosed from 2018 to 2022 were included in the analysis. Compared with the prepandemic stage (2018-2020), the risk of patient delay did not decrease significantly during the pandemic of COVID-19 (P > 0.05), but the risk of diagnosis delay showed different trends at different stages throughout the pandemic. The risk of diagnosis delay decreased in Changzhou (HR: 1.18, 95% CI: 1.12-1.24), but it increased in Suzhou (HR: 0.92, 95% CI: 0.88-0.96).
conclusionsThe impact of the COVID-19 pandemic on tuberculosis varied by region and population. It is necessary to respond in a timely and precise manner according to the scope of the disease pandemic, accessibility of medical resources, and population literacy to reduce the adverse impacts of other disease epidemics on tuberculosis prevention and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.